ICAM-1-mediated adhesion is a prerequisite for exosome-induced T cell suppression
Tumor-derived extracellular vesicles (TEVs) suppress the proliferation and cytotoxicity of CD8+ T cells, thereby contributing to tumor immune evasion. Here, we report that the adhesion molecule intercellular adhesion molecule 1 (ICAM-1) co-localizes with programmed death ligand 1 (PD-L1) on the exos...
Saved in:
Published in | Developmental cell Vol. 57; no. 3; pp. 329 - 343.e7 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
07.02.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Tumor-derived extracellular vesicles (TEVs) suppress the proliferation and cytotoxicity of CD8+ T cells, thereby contributing to tumor immune evasion. Here, we report that the adhesion molecule intercellular adhesion molecule 1 (ICAM-1) co-localizes with programmed death ligand 1 (PD-L1) on the exosomes; both ICAM-1 and PD-L1 are upregulated by interferon-γ. Exosomal ICAM-1 interacts with LFA-1, which is upregulated in activated T cells. Blocking ICAM-1 on TEVs reduces the interaction of TEVs with CD8+ T cells and attenuates PD-L1-mediated suppressive effects of TEVs. During this study, we have established an extracellular vesicle-target cell interaction detection through SorTagging (ETIDS) system to assess the interaction between a TEV ligand and its target cell receptor. Using this system, we demonstrate that the interaction of TEV PD-L1 with programmed cell death 1 (PD-1) on T cells is significantly reduced in the absence of ICAM-1. Our study demonstrates that ICAM-1-LFA-1-mediated adhesion between TEVs and T cells is a prerequisite for exosomal PD-L1-mediated immune suppression.
[Display omitted]
•ICAM-1 and PD-L1 co-localize on exosomes and are both upregulated by interferon-γ•ICAM-1 is a prerequisite for exosomal PD-L1-mediated inhibition of CD8+ T cells•Reciprocal upregulation of ICAM-1 and LFA-1 promotes exosome-T cell interaction•Established an assay system for the interaction of exosomal PD-L1 with PD-1 on T cells
Tumor-derived exosomes can suppress the proliferation and cytotoxicity of CD8+ T cells. Zhang and colleagues report that the exosomes adhere to activated CD8 T cells through an ICAM-1-LFA-1 interaction, which is a prerequisite for exosomal PD-L1-PD-1 binding and T cell suppression. |
---|---|
AbstractList | Tumor-derived extracellular vesicles (TEVs) suppress the proliferation and cytotoxicity of CD8+ T cells, thereby contributing to tumor immune evasion. Here, we report that the adhesion molecule intercellular adhesion molecule 1 (ICAM-1) co-localizes with programmed death ligand 1 (PD-L1) on the exosomes; both ICAM-1 and PD-L1 are upregulated by interferon-γ. Exosomal ICAM-1 interacts with LFA-1, which is upregulated in activated T cells. Blocking ICAM-1 on TEVs reduces the interaction of TEVs with CD8+ T cells and attenuates PD-L1-mediated suppressive effects of TEVs. During this study, we have established an extracellular vesicle-target cell interaction detection through SorTagging (ETIDS) system to assess the interaction between a TEV ligand and its target cell receptor. Using this system, we demonstrate that the interaction of TEV PD-L1 with programmed cell death 1 (PD-1) on T cells is significantly reduced in the absence of ICAM-1. Our study demonstrates that ICAM-1-LFA-1-mediated adhesion between TEVs and T cells is a prerequisite for exosomal PD-L1-mediated immune suppression.
[Display omitted]
•ICAM-1 and PD-L1 co-localize on exosomes and are both upregulated by interferon-γ•ICAM-1 is a prerequisite for exosomal PD-L1-mediated inhibition of CD8+ T cells•Reciprocal upregulation of ICAM-1 and LFA-1 promotes exosome-T cell interaction•Established an assay system for the interaction of exosomal PD-L1 with PD-1 on T cells
Tumor-derived exosomes can suppress the proliferation and cytotoxicity of CD8+ T cells. Zhang and colleagues report that the exosomes adhere to activated CD8 T cells through an ICAM-1-LFA-1 interaction, which is a prerequisite for exosomal PD-L1-PD-1 binding and T cell suppression. Tumor-derived extracellular vesicles (TEVs) suppress the proliferation and cytotoxicity of CD8 + T cells, thereby contributing to tumor immune evasion. Here we report that the adhesion molecule ICAM-1 co-localizes with PD-L1 on the exosomes; both ICAM-1 and PD-L1 are upregulated by interferon-γ. Exosomal ICAM-1 interacts with LFA-1, which is upregulated on activated T cells. Blocking ICAM-1 on TEVs reduces the interaction of TEVs with CD8 + T cells, and attenuates PD-L1-mediated suppressive effects of TEVs. During this study, we have established an E xtracellular vesicle- T arget cell I nteraction D etection through S orTagging (ETIDS) system to assess the interaction between a TEV ligand and its target cell receptor. Using this system, we demonstrate that the interaction of TEV PD-L1 with PD-1 on T cells is significantly reduced in the absence of ICAM-1. Our study demonstrates that ICAM-1-LFA-1 mediated adhesion between TEVs and T cells is a prerequisite for exosomal PD-L1 mediated immune suppression. Tumor-derived exosomes can suppress the proliferation and cytotoxicity of CD8+ T cells. Zhang and colleagues report that the exosomes adhere to activated CD8 T cells through an ICAM-1-LFA-1 interaction, which is a prerequisite for exosomal PD-L1-PD-1 binding and T cell suppression. Tumor-derived extracellular vesicles (TEVs) suppress the proliferation and cytotoxicity of CD8+ T cells, thereby contributing to tumor immune evasion. Here, we report that the adhesion molecule intercellular adhesion molecule 1 (ICAM-1) co-localizes with programmed death ligand 1 (PD-L1) on the exosomes; both ICAM-1 and PD-L1 are upregulated by interferon-γ. Exosomal ICAM-1 interacts with LFA-1, which is upregulated in activated T cells. Blocking ICAM-1 on TEVs reduces the interaction of TEVs with CD8+ T cells and attenuates PD-L1-mediated suppressive effects of TEVs. During this study, we have established an extracellular vesicle-target cell interaction detection through SorTagging (ETIDS) system to assess the interaction between a TEV ligand and its target cell receptor. Using this system, we demonstrate that the interaction of TEV PD-L1 with programmed cell death 1 (PD-1) on T cells is significantly reduced in the absence of ICAM-1. Our study demonstrates that ICAM-1-LFA-1-mediated adhesion between TEVs and T cells is a prerequisite for exosomal PD-L1-mediated immune suppression.Tumor-derived extracellular vesicles (TEVs) suppress the proliferation and cytotoxicity of CD8+ T cells, thereby contributing to tumor immune evasion. Here, we report that the adhesion molecule intercellular adhesion molecule 1 (ICAM-1) co-localizes with programmed death ligand 1 (PD-L1) on the exosomes; both ICAM-1 and PD-L1 are upregulated by interferon-γ. Exosomal ICAM-1 interacts with LFA-1, which is upregulated in activated T cells. Blocking ICAM-1 on TEVs reduces the interaction of TEVs with CD8+ T cells and attenuates PD-L1-mediated suppressive effects of TEVs. During this study, we have established an extracellular vesicle-target cell interaction detection through SorTagging (ETIDS) system to assess the interaction between a TEV ligand and its target cell receptor. Using this system, we demonstrate that the interaction of TEV PD-L1 with programmed cell death 1 (PD-1) on T cells is significantly reduced in the absence of ICAM-1. Our study demonstrates that ICAM-1-LFA-1-mediated adhesion between TEVs and T cells is a prerequisite for exosomal PD-L1-mediated immune suppression. Tumor-derived extracellular vesicles (TEVs) suppress the proliferation and cytotoxicity of CD8 T cells, thereby contributing to tumor immune evasion. Here, we report that the adhesion molecule intercellular adhesion molecule 1 (ICAM-1) co-localizes with programmed death ligand 1 (PD-L1) on the exosomes; both ICAM-1 and PD-L1 are upregulated by interferon-γ. Exosomal ICAM-1 interacts with LFA-1, which is upregulated in activated T cells. Blocking ICAM-1 on TEVs reduces the interaction of TEVs with CD8 T cells and attenuates PD-L1-mediated suppressive effects of TEVs. During this study, we have established an extracellular vesicle-target cell interaction detection through SorTagging (ETIDS) system to assess the interaction between a TEV ligand and its target cell receptor. Using this system, we demonstrate that the interaction of TEV PD-L1 with programmed cell death 1 (PD-1) on T cells is significantly reduced in the absence of ICAM-1. Our study demonstrates that ICAM-1-LFA-1-mediated adhesion between TEVs and T cells is a prerequisite for exosomal PD-L1-mediated immune suppression. |
Author | Yu, Ziyan Zheng, Cathy Mitchell, Tara C. Daaboul, George Yang, Jingbo Wang, Beike Zhang, Wei Shi, Alex Xu, Wei Schuchter, Lynn M. Amaravadi, Ravi Gimotty, Phyllis A. Yang, Jiegang Karakousis, Giorgos C. Guo, Wei Zhong, Wenqun Dong, Haidong Xu, Xiaowei Qin, Zhiyuan Herlyn, Meenhard |
AuthorAffiliation | 4 Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA19104, USA 5 Molecular and Cellular Oncogenesis Program and Melanoma Research Center, The Wistar Institute, Philadelphia, PA19104, USA 9 Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA19104, USA 6 Departments of Urology and Immunology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA 7 Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, PA 19104, USA 3 Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA19104, USA 8 NanoView Biosciences, Inc., Boston, MA 02135, USA 2 Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA19104, USA 1 Department of Biology, School of Arts & Sciences, University of Pennsylvania, Philadelphia, PA19104, USA |
AuthorAffiliation_xml | – name: 4 Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA19104, USA – name: 6 Departments of Urology and Immunology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA – name: 1 Department of Biology, School of Arts & Sciences, University of Pennsylvania, Philadelphia, PA19104, USA – name: 5 Molecular and Cellular Oncogenesis Program and Melanoma Research Center, The Wistar Institute, Philadelphia, PA19104, USA – name: 2 Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA19104, USA – name: 3 Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA19104, USA – name: 7 Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, PA 19104, USA – name: 8 NanoView Biosciences, Inc., Boston, MA 02135, USA – name: 9 Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA19104, USA |
Author_xml | – sequence: 1 givenname: Wei surname: Zhang fullname: Zhang, Wei organization: Department of Biology, School of Arts & Sciences, University of Pennsylvania, Philadelphia, PA 19104, USA – sequence: 2 givenname: Wenqun surname: Zhong fullname: Zhong, Wenqun organization: Department of Biology, School of Arts & Sciences, University of Pennsylvania, Philadelphia, PA 19104, USA – sequence: 3 givenname: Beike surname: Wang fullname: Wang, Beike organization: Department of Biology, School of Arts & Sciences, University of Pennsylvania, Philadelphia, PA 19104, USA – sequence: 4 givenname: Jiegang surname: Yang fullname: Yang, Jiegang organization: Department of Biology, School of Arts & Sciences, University of Pennsylvania, Philadelphia, PA 19104, USA – sequence: 5 givenname: Jingbo surname: Yang fullname: Yang, Jingbo organization: Department of Biology, School of Arts & Sciences, University of Pennsylvania, Philadelphia, PA 19104, USA – sequence: 6 givenname: Ziyan surname: Yu fullname: Yu, Ziyan organization: Department of Biology, School of Arts & Sciences, University of Pennsylvania, Philadelphia, PA 19104, USA – sequence: 7 givenname: Zhiyuan surname: Qin fullname: Qin, Zhiyuan organization: Department of Biology, School of Arts & Sciences, University of Pennsylvania, Philadelphia, PA 19104, USA – sequence: 8 givenname: Alex surname: Shi fullname: Shi, Alex organization: Department of Biology, School of Arts & Sciences, University of Pennsylvania, Philadelphia, PA 19104, USA – sequence: 9 givenname: Wei surname: Xu fullname: Xu, Wei organization: Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA – sequence: 10 givenname: Cathy surname: Zheng fullname: Zheng, Cathy organization: Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA – sequence: 11 givenname: Lynn M. surname: Schuchter fullname: Schuchter, Lynn M. organization: Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA – sequence: 12 givenname: Giorgos C. surname: Karakousis fullname: Karakousis, Giorgos C. organization: Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA – sequence: 13 givenname: Tara C. surname: Mitchell fullname: Mitchell, Tara C. organization: Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA – sequence: 14 givenname: Ravi surname: Amaravadi fullname: Amaravadi, Ravi organization: Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA – sequence: 15 givenname: Meenhard surname: Herlyn fullname: Herlyn, Meenhard organization: Molecular and Cellular Oncogenesis Program and Melanoma Research Center, The Wistar Institute, Philadelphia, PA 19104, USA – sequence: 16 givenname: Haidong surname: Dong fullname: Dong, Haidong organization: Departments of Urology and Immunology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA – sequence: 17 givenname: Phyllis A. surname: Gimotty fullname: Gimotty, Phyllis A. organization: Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA – sequence: 18 givenname: George surname: Daaboul fullname: Daaboul, George organization: NanoView Biosciences, Inc., Boston, MA 02135, USA – sequence: 19 givenname: Xiaowei surname: Xu fullname: Xu, Xiaowei organization: Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA – sequence: 20 givenname: Wei surname: Guo fullname: Guo, Wei email: guowei@sas.upenn.edu organization: Department of Biology, School of Arts & Sciences, University of Pennsylvania, Philadelphia, PA 19104, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35085484$$D View this record in MEDLINE/PubMed |
BookMark | eNp9Uctu2zAQJAoHjZ30D4JCx1yk8q31pUBgpA_AQYDAd4ISVwkNW3RIyUj-Jt_SLysNp2l7yYkLcGZ2dmZGJn3okZALRitGmf6yrhzuW9xUnHJeUVZRyj-QKYMaSqYUm-RZCVkqoPUpmaW0ppnGgH4kp0JRUBLklNz9XFzdlKzcovN2QFdY94DJh77wqbDFLmLEx9EnP2DRhVjgU0hhi6Xv3dhm-OrXS_awKdK4y9h0YJ6Tk85uEn56fc_I6tv1avGjXN5-z9uWZSu1GEo5b2plXS3nqoHs0TpuNZW10i10qBuGGrTlwEFwJZtONwIEKqdZI5DV4ox8Pcruxia7b7Efot2YXfRbG59NsN78_9P7B3Mf9gYAWD2fZ4HLV4EYHkdMg9n6dDjG9hjGZLjmAkBQBhkqj9A2hpQidm9rGDWHNszaHNswhzYMZSa3kWmf_7X4RvoT_98bMOe09xhNaj32OVgfsR2MC_79Db8BgTCgPg |
CitedBy_id | crossref_primary_10_1038_s41467_023_36892_4 crossref_primary_10_3389_fcell_2023_1228624 crossref_primary_10_1038_s41419_023_05647_w crossref_primary_10_1038_s41698_022_00287_3 crossref_primary_10_3389_fimmu_2022_958360 crossref_primary_10_1007_s12013_024_01340_7 crossref_primary_10_1515_med_2024_0969 crossref_primary_10_3390_cells13040339 crossref_primary_10_1038_s41598_022_25811_0 crossref_primary_10_1002_advs_202303230 crossref_primary_10_1016_j_gendis_2023_04_007 crossref_primary_10_1016_j_tcb_2023_06_006 crossref_primary_10_1186_s12964_023_01236_8 crossref_primary_10_1111_cas_15532 crossref_primary_10_1038_s41467_024_48200_9 crossref_primary_10_1158_2326_6066_CIR_22_0277 crossref_primary_10_3390_vaccines10101691 crossref_primary_10_1016_j_phrs_2024_107179 crossref_primary_10_1016_j_phrs_2022_106364 crossref_primary_10_1186_s12964_024_01521_0 crossref_primary_10_1016_j_prp_2024_155288 crossref_primary_10_1038_s41467_023_40850_5 crossref_primary_10_1093_cei_uxae026 crossref_primary_10_1016_j_ymthe_2023_06_005 crossref_primary_10_1152_ajplung_00244_2023 crossref_primary_10_1016_j_trecan_2022_05_002 crossref_primary_10_3389_fonc_2023_1135122 crossref_primary_10_1016_j_bbcan_2023_188908 crossref_primary_10_1002_advs_202404064 crossref_primary_10_1007_s10555_024_10189_4 crossref_primary_10_1002_smll_202301019 crossref_primary_10_1158_0008_5472_CAN_22_2220 crossref_primary_10_3389_fcimb_2023_1240516 crossref_primary_10_1038_s41416_023_02369_w crossref_primary_10_3390_cancers15041097 crossref_primary_10_3389_fimmu_2024_1395332 crossref_primary_10_1007_s13659_023_00375_2 crossref_primary_10_3390_ijms232112971 crossref_primary_10_1002_jev2_12322 crossref_primary_10_1111_nyas_14974 crossref_primary_10_1073_pnas_2210047120 crossref_primary_10_1186_s13287_023_03594_z crossref_primary_10_1007_s00262_023_03562_9 crossref_primary_10_3389_fimmu_2022_1002551 crossref_primary_10_1021_acs_analchem_2c03725 crossref_primary_10_1126_sciadv_adg1082 crossref_primary_10_3389_fimmu_2024_1376962 crossref_primary_10_3390_cells12081136 crossref_primary_10_1016_j_drup_2024_101112 crossref_primary_10_3390_ijms24020965 crossref_primary_10_3390_ijms25063449 |
Cites_doi | 10.1038/nature21349 10.1038/nm730 10.5772/61186 10.1016/j.cell.2016.01.043 10.1126/science.aau6977 10.4161/onci.23972 10.3389/fimmu.2018.00952 10.1038/nature25442 10.1146/annurev-immunol-032414-112049 10.1038/s41422-018-0060-4 10.1016/j.celrep.2018.06.066 10.1074/jbc.M116.763888 10.1016/j.bbrc.2010.05.094 10.1158/0008-5472.CAN-08-0719 10.1158/1078-0432.CCR-17-2664 10.1080/2162402X.2016.1261243 10.3389/fimmu.2018.00847 10.1016/j.cell.2019.02.016 10.1245/s10434-019-07431-7 10.1158/0008-5472.CAN-12-2569 10.1158/2159-8290.CD-18-0367 10.1159/000053691 10.1111/j.1346-8138.1997.tb02805.x 10.1038/nmeth.3047 10.1182/blood-2008-08-174094 10.3389/fimmu.2019.01078 10.3389/fcell.2018.00018 10.1016/j.cell.2017.01.017 10.1016/j.cub.2012.01.028 10.1126/sciadv.aar2766 10.1038/nature15756 10.1186/ar559 10.1182/blood-2004-03-0824 10.1146/annurev-cellbio-101512-122326 10.1016/j.ijrobp.2018.09.001 10.1038/s41586-018-0392-8 10.1016/j.semcdb.2017.08.022 10.1126/science.aar4060 10.4049/jimmunol.130.4.1784 10.4049/jimmunol.161.8.4016 10.1038/nmeth.2019 10.1111/pcmr.12498 10.1093/nar/gks1215 10.3349/ymj.1995.36.1.15 10.1111/j.1365-2567.2008.02888.x 10.1016/j.immuni.2019.12.011 10.1016/j.trecan.2020.03.002 10.1182/blood-2005-01-0220 10.1186/s12967-019-2101-2 10.1152/ajpcell.00228.2013 10.1038/ncb2000 |
ContentType | Journal Article |
Copyright | 2022 Elsevier Inc. Copyright © 2022 Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: 2022 Elsevier Inc. – notice: Copyright © 2022 Elsevier Inc. All rights reserved. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM |
DOI | 10.1016/j.devcel.2022.01.002 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1878-1551 |
EndPage | 343.e7 |
ExternalDocumentID | 10_1016_j_devcel_2022_01_002 35085484 S1534580722000028 |
Genre | Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NCI NIH HHS grantid: P50 CA261608 – fundername: NCI NIH HHS grantid: P30 CA010815 – fundername: NIGMS NIH HHS grantid: R35 GM141832 – fundername: NCI NIH HHS grantid: P50 CA174523 – fundername: NCI NIH HHS grantid: U01 CA250044 |
GroupedDBID | --- --K 0R~ 1~5 2WC 4.4 457 4G. 5GY 62- 7-5 AACTN AAEDW AAFTH AAIAV AAKRW AALRI AAUCE AAVLU AAXUO ABJNI ABMAC ABMWF ABVKL ACGFO ACGFS ACNCT ADBBV ADEZE ADJPV AEFWE AENEX AEXQZ AFFNX AFTJW AGKMS AITUG ALKID ALMA_UNASSIGNED_HOLDINGS AMRAJ ASPBG AVWKF AZFZN BAWUL CS3 D0L DIK DU5 E3Z EBS EJD F5P FCP FDB FEDTE FIRID HVGLF IHE IXB J1W JIG M3Z M41 O-L O9- OK1 P2P RCE ROL RPZ SDG SES SSZ TR2 WQ6 ZA5 0SF AAEDT AAMRU ADVLN AKAPO AKRWK CGR CUY CVF ECM EIF NPM RIG 29F 53G 5VS 6I. AAIKJ AAQFI AAQXK AAYXX ADMUD AGHFR CITATION FGOYB HZ~ NCXOZ OZT R2- UHS 7X8 5PM |
ID | FETCH-LOGICAL-c463t-49b75ad7495b8807ad2a604756c8fe6b1e686a28283254bf6b383e5d61b3e173 |
IEDL.DBID | ABVKL |
ISSN | 1534-5807 1878-1551 |
IngestDate | Tue Sep 17 21:30:31 EDT 2024 Sat Oct 26 04:19:09 EDT 2024 Thu Sep 26 17:50:40 EDT 2024 Sat Nov 02 12:09:15 EDT 2024 Fri Feb 23 02:43:58 EST 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | PD-L1 CD8+ T cells ICAM-1 extracellular vesicles immune suppression exosome CD8(+) T cells |
Language | English |
License | Copyright © 2022 Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c463t-49b75ad7495b8807ad2a604756c8fe6b1e686a28283254bf6b383e5d61b3e173 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Wei Zhang and Wenqun Zhong contributed equally to this work. W.Z. and W.G. conceived the project and designed the experiments. W.Z., W.Zho., B.W., and Jie.Y. purified and characterized extracellular vesicles. W.Z., W.Zho., B.W., Jie.Y., Jin.Y. and Z.Y. performed the mice experiments. W.Z. and W.Zho. established knockdown and knockout cell lines, collected exosomes and performed the T cell binding assays, the T cell proliferation and activation assays. W.Z., W. Zho. and Z.Q. performed ELISA assays. W.Z., W. Zho. and B.W. performed the nanoparticle tracking analysis. W.Z., W. Zho., B.W., Jie.Y. and A.S. performed the immunoprecipitation and western blot analysis. W.Z. established EDITS system and tested the exosomal PD-L1/PD-1 interaction. W. Zho performed immune-TEM and ICAM-1+ exosome depletion assays. W.Z., W.Zho. and Jin. Y. performed the flow cytometry experiments. X.X. performed pathological analyses. W.X., C.Z., L.M.S., G.C.K., T.C.M. and R.A. provided human samples and associated clinical data. M.H., and H.D. provided antibodies and cell lines. W.Z., W.Zho., B.W., Jie.Y. analyzed and interpreted the data. W.Z. and P.A.G. performed the statistical analysis. W.Z., W.Zho. and W.G. wrote the paper. A.S., W.X., R.A. and X.X. edited the paper. All authors have read and approved the final manuscript. Lead contact Author contributions |
OpenAccessLink | https://doi.org/10.1016/j.devcel.2022.01.002 |
PMID | 35085484 |
PQID | 2623883018 |
PQPubID | 23479 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_8881799 proquest_miscellaneous_2623883018 crossref_primary_10_1016_j_devcel_2022_01_002 pubmed_primary_35085484 elsevier_sciencedirect_doi_10_1016_j_devcel_2022_01_002 |
PublicationCentury | 2000 |
PublicationDate | 2022-02-07 |
PublicationDateYYYYMMDD | 2022-02-07 |
PublicationDate_xml | – month: 02 year: 2022 text: 2022-02-07 day: 07 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Developmental cell |
PublicationTitleAlternate | Dev Cell |
PublicationYear | 2022 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Hegde, Chen (bib13) 2020; 52 Schindelin, Arganda-Carreras, Frise, Kaynig, Longair, Pietzsch, Preibisch, Rueden, Saalfeld, Schmid (bib41) 2012; 9 Li, Li, Zhi, Liang, Wang, Chen, Lv, Shen, Song, Lin, Liu (bib21) 2019; 17 Meeth, Wang, Micevic, Damsky, Bosenberg (bib27) 2016; 29 Dong, Strome, Salomao, Tamura, Hirano, Flies, Roche, Lu, Zhu, Tamada (bib6) 2002; 8 Markel, Seidman, Cohen, Besser, Sinai, Treves, Orenstein, Berger, Schachter (bib25) 2009; 126 Tominaga, Kita, Satoh, Asai, Kato, Ishikawa, Horiuchi, Takashi (bib48) 1998; 161 Turturici, Tinnirello, Sconzo, Geraci (bib49) 2014; 306 Evans, Morris, Zhang, Cao, Liu, Mara, Stish, Davis, Mansfield, Dronca (bib8) 2019; 103 Hoshino, Costa-Silva, Shen, Rodrigues, Hashimoto, Tesic Mark, Molina, Kohsaka, Di Giannatale, Ceder (bib14) 2015; 527 Franciszkiewicz, Le Floc'h, Boutet, Vergnon, Schmitt, Mami-Chouaib (bib10) 2013; 73 Segura, Nicco, Lombard, Véron, Raposo, Batteux, Amigorena, Théry (bib43) 2005; 106 Nakayama, Guan, Nakashima, Mashino, Hori (bib32) 1997; 24 Pasqual, Chudnovskiy, Tas, Agudelo, Schweitzer, Cui, Hacohen, Victora (bib35) 2018; 553 Sharma, Hu-Lieskovan, Wargo, Ribas (bib44) 2017; 168 Ricklefs, Alayo, Krenzlin, Mahmoud, Speranza, Nakashima, Hayes, Lee, Balaj, Passaro (bib38) 2018; 4 Theodoraki, Yerneni, Hoffmann, Gooding, Whiteside (bib46) 2018; 24 Castro, Cardoso, Gonçalves, Serre, Oliveira (bib2) 2018; 9 Li, Cheng, Tilevik, Davis, Zhu (bib22) 2017; 292 Baumeister, Freeman, Dranoff, Sharpe (bib1) 2016; 34 Nolte-'t Hoen, Buschow, Anderton, Stoorvogel, Wauben (bib33) 2009; 113 Ribas, Wolchok (bib37) 2018; 359 Juan, Fürthauer (bib15) 2018; 74 Yang, Li, Chan, Wei, Hsu, Xia, Cha, Hou, Hsu, Sun (bib52) 2018; 28 Monypenny, Milewicz, Flores-Borja, Weitsman, Cheung, Chowdhury, Burgoyne, Arulappu, Lawler, Barber (bib28) 2018; 24 Maia, Caja, Strano Moraes, Couto, Costa-Silva (bib24) 2018; 6 Walling, Kim (bib50) 2018; 9 Kim, Lee, Park, Lee, Kim, Kim (bib19) 1995; 36 McKelvey, Powell, Ashton, Morris, McCracken (bib26) 2015; 4 Colombo, Raposo, Théry (bib5) 2014; 30 Wei, Duffy, Allison (bib51) 2018; 8 Fan, Che, Qu, Hou, Wen, Li, Li, Wang, Xu, Liu, Qu (bib9) 2019; 26 Chen, Huang, Zhang, Zhang, Wu, Xu, Yu, Yang, Wang, Sun (bib4) 2018; 560 Kalluri, LeBleu (bib16) 2020; 367 Harjunpää, Llort Asens, Guenther, Fagerholm (bib12) 2019; 10 Muller, Simms, Hong, Nishimura, Jackson, Watkins, Whiteside (bib31) 2017; 6 Tkach, Théry (bib47) 2016; 164 Skokos, Le Panse, Villa, Rousselle, Peronet, Namane, David, Mécheri (bib45) 2001; 124 Rusinova, Forster, Yu, Kannan, Masse, Cumming, Chapman, Hertzog (bib39) 2013; 41 Lee, Choi, Kim, Kim, Kim, Kang, Gho (bib20) 2010; 397 Kasahara, Hooks, Dougherty, Oppenheim (bib17) 1983; 130 Sanjana, Shalem, Zhang (bib40) 2014; 11 Liu, Gibbons, Harrington, Krco, Markovic, Kwon, Dong (bib23) 2013; 2 Dustin (bib7) 2002; 4 Ostrowski, Carmo, Krumeich, Fanget, Raposo, Savina, Moita, Schauer, Hume, Freitas (bib34) 2010; 12 Poggio, Hu, Pai, Chu, Belair, Chang, Montabana, Lang, Fu, Fong, Blelloch (bib36) 2019; 177 Morrissey, Yan (bib30) 2020; 6 Chen, Mellman (bib3) 2017; 541 Morelli, Larregina, Shufesky, Sullivan, Stolz, Papworth, Zahorchak, Logar, Wang, Watkins (bib29) 2004; 104 Hamaï, Meslin, Benlalam, Jalil, Mehrpour, Faure, Lecluse, Vielh, Avril, Robert, Chouaib (bib11) 2008; 68 Schmidt, Teis (bib42) 2012; 22 Kim, Kim, Choi, Kim, Lee, Sung, Sung, Pack, Jung, Han (bib18) 2019; 51 Monypenny (10.1016/j.devcel.2022.01.002_bib28) 2018; 24 Nolte-'t Hoen (10.1016/j.devcel.2022.01.002_bib33) 2009; 113 Harjunpää (10.1016/j.devcel.2022.01.002_bib12) 2019; 10 Chen (10.1016/j.devcel.2022.01.002_bib4) 2018; 560 Sanjana (10.1016/j.devcel.2022.01.002_bib40) 2014; 11 Markel (10.1016/j.devcel.2022.01.002_bib25) 2009; 126 Meeth (10.1016/j.devcel.2022.01.002_bib27) 2016; 29 Turturici (10.1016/j.devcel.2022.01.002_bib49) 2014; 306 Theodoraki (10.1016/j.devcel.2022.01.002_bib46) 2018; 24 Segura (10.1016/j.devcel.2022.01.002_bib43) 2005; 106 Kasahara (10.1016/j.devcel.2022.01.002_bib17) 1983; 130 Wei (10.1016/j.devcel.2022.01.002_bib51) 2018; 8 Maia (10.1016/j.devcel.2022.01.002_bib24) 2018; 6 Sharma (10.1016/j.devcel.2022.01.002_bib44) 2017; 168 Tkach (10.1016/j.devcel.2022.01.002_bib47) 2016; 164 Castro (10.1016/j.devcel.2022.01.002_bib2) 2018; 9 Walling (10.1016/j.devcel.2022.01.002_bib50) 2018; 9 Franciszkiewicz (10.1016/j.devcel.2022.01.002_bib10) 2013; 73 Kalluri (10.1016/j.devcel.2022.01.002_bib16) 2020; 367 Baumeister (10.1016/j.devcel.2022.01.002_bib1) 2016; 34 Ostrowski (10.1016/j.devcel.2022.01.002_bib34) 2010; 12 McKelvey (10.1016/j.devcel.2022.01.002_bib26) 2015; 4 Rusinova (10.1016/j.devcel.2022.01.002_bib39) 2013; 41 Morelli (10.1016/j.devcel.2022.01.002_bib29) 2004; 104 Yang (10.1016/j.devcel.2022.01.002_bib52) 2018; 28 Evans (10.1016/j.devcel.2022.01.002_bib8) 2019; 103 Dong (10.1016/j.devcel.2022.01.002_bib6) 2002; 8 Nakayama (10.1016/j.devcel.2022.01.002_bib32) 1997; 24 Hegde (10.1016/j.devcel.2022.01.002_bib13) 2020; 52 Lee (10.1016/j.devcel.2022.01.002_bib20) 2010; 397 Poggio (10.1016/j.devcel.2022.01.002_bib36) 2019; 177 Tominaga (10.1016/j.devcel.2022.01.002_bib48) 1998; 161 Schmidt (10.1016/j.devcel.2022.01.002_bib42) 2012; 22 Ribas (10.1016/j.devcel.2022.01.002_bib37) 2018; 359 Pasqual (10.1016/j.devcel.2022.01.002_bib35) 2018; 553 Hoshino (10.1016/j.devcel.2022.01.002_bib14) 2015; 527 Kim (10.1016/j.devcel.2022.01.002_bib18) 2019; 51 Morrissey (10.1016/j.devcel.2022.01.002_bib30) 2020; 6 Schindelin (10.1016/j.devcel.2022.01.002_bib41) 2012; 9 Colombo (10.1016/j.devcel.2022.01.002_bib5) 2014; 30 Dustin (10.1016/j.devcel.2022.01.002_bib7) 2002; 4 Kim (10.1016/j.devcel.2022.01.002_bib19) 1995; 36 Skokos (10.1016/j.devcel.2022.01.002_bib45) 2001; 124 Chen (10.1016/j.devcel.2022.01.002_bib3) 2017; 541 Fan (10.1016/j.devcel.2022.01.002_bib9) 2019; 26 Hamaï (10.1016/j.devcel.2022.01.002_bib11) 2008; 68 Juan (10.1016/j.devcel.2022.01.002_bib15) 2018; 74 Li (10.1016/j.devcel.2022.01.002_bib22) 2017; 292 Liu (10.1016/j.devcel.2022.01.002_bib23) 2013; 2 Muller (10.1016/j.devcel.2022.01.002_bib31) 2017; 6 Li (10.1016/j.devcel.2022.01.002_bib21) 2019; 17 Ricklefs (10.1016/j.devcel.2022.01.002_bib38) 2018; 4 |
References_xml | – volume: 103 start-page: 229 year: 2019 end-page: 240 ident: bib8 article-title: Prospective immunophenotyping of CD8(+) T cells and associated clinical outcomes of patients with oligometastatic prostate cancer treated with metastasis-directed SBRT publication-title: Int. J. Radiat. Oncol. Biol. Phys. contributor: fullname: Dronca – volume: 17 start-page: 355 year: 2019 ident: bib21 article-title: Clinical significance of PD-L1 expression in serum-derived exosomes in NSCLC patients publication-title: J. Transl. Med. contributor: fullname: Liu – volume: 6 start-page: e1261243 year: 2017 ident: bib31 article-title: Human tumor-derived exosomes (TEX) regulate Treg functions via cell surface signaling rather than uptake mechanisms publication-title: Oncoimmunology contributor: fullname: Whiteside – volume: 113 start-page: 1977 year: 2009 end-page: 1981 ident: bib33 article-title: Activated T cells recruit exosomes secreted by dendritic cells via LFA-1 publication-title: Blood contributor: fullname: Wauben – volume: 130 start-page: 1784 year: 1983 end-page: 1789 ident: bib17 article-title: Interleukin 2-mediated immune interferon (IFN-gamma) production by human T cells and T cell subsets publication-title: J. Immunol. contributor: fullname: Oppenheim – volume: 29 start-page: 590 year: 2016 end-page: 597 ident: bib27 article-title: The YUMM lines: a series of congenic mouse melanoma cell lines with defined genetic alterations publication-title: Pigment Cell Melanoma Res contributor: fullname: Bosenberg – volume: 12 start-page: 19 year: 2010 end-page: 30 ident: bib34 article-title: Rab27a and Rab27b control different steps of the exosome secretion pathway publication-title: Nat. Cell Biol. contributor: fullname: Freitas – volume: 24 start-page: 896 year: 2018 end-page: 905 ident: bib46 article-title: Clinical significance of PD-L1(+) exosomes in plasma of head and neck cancer patients publication-title: Clin. Cancer Res. contributor: fullname: Whiteside – volume: 541 start-page: 321 year: 2017 end-page: 330 ident: bib3 article-title: Elements of cancer immunity and the cancer-immune set point publication-title: Nature contributor: fullname: Mellman – volume: 177 start-page: 414 year: 2019 end-page: 427.e13 ident: bib36 article-title: Suppression of Exosomal PD-L1 induces systemic anti-tumor immunity and memory publication-title: Cell contributor: fullname: Blelloch – volume: 527 start-page: 329 year: 2015 end-page: 335 ident: bib14 article-title: Tumour exosome integrins determine organotropic metastasis publication-title: Nature contributor: fullname: Ceder – volume: 24 start-page: 351 year: 1997 end-page: 360 ident: bib32 article-title: In vitro comparison between mouse B16 and human melanoma cell lines of the expression of ICAM-1 induced by cytokines and/or hyperthermia publication-title: J. Dermatol. contributor: fullname: Hori – volume: 397 start-page: 251 year: 2010 end-page: 256 ident: bib20 article-title: A membranous form of ICAM-1 on exosomes efficiently blocks leukocyte adhesion to activated endothelial cells publication-title: Biochem. Biophys. Res. Commun. contributor: fullname: Gho – volume: 6 start-page: 18 year: 2018 ident: bib24 article-title: Exosome-based cell-cell communication in the tumor microenvironment publication-title: Front. Cell Dev. Biol. contributor: fullname: Costa-Silva – volume: 28 start-page: 862 year: 2018 end-page: 864 ident: bib52 article-title: Exosomal PD-L1 harbors active defense function to suppress T cell killing of breast cancer cells and promote tumor growth publication-title: Cell Res. contributor: fullname: Sun – volume: 8 start-page: 1069 year: 2018 end-page: 1086 ident: bib51 article-title: Fundamental mechanisms of immune checkpoint blockade therapy publication-title: Cancer Discov. contributor: fullname: Allison – volume: 11 start-page: 783 year: 2014 end-page: 784 ident: bib40 article-title: Improved vectors and genome-wide libraries for CRISPR screening publication-title: Nat. Methods contributor: fullname: Zhang – volume: 41 start-page: D1040 year: 2013 end-page: D1046 ident: bib39 article-title: Interferome v2.0: an updated database of annotated interferon-regulated genes publication-title: Nucleic Acids Res. contributor: fullname: Hertzog – volume: 9 start-page: 952 year: 2018 ident: bib50 article-title: LFA-1 in T cell migration and differentiation publication-title: Front. Immunol. contributor: fullname: Kim – volume: 161 start-page: 4016 year: 1998 end-page: 4022 ident: bib48 article-title: Affinity and kinetic analysis of the molecular interaction of ICAM-1 and leukocyte function-associated antigen-1 publication-title: J. Immunol. contributor: fullname: Takashi – volume: 104 start-page: 3257 year: 2004 end-page: 3266 ident: bib29 article-title: Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells publication-title: Blood contributor: fullname: Watkins – volume: 52 start-page: 17 year: 2020 end-page: 35 ident: bib13 article-title: Top 10 challenges in cancer immunotherapy publication-title: Immunity contributor: fullname: Chen – volume: 24 start-page: 630 year: 2018 end-page: 641 ident: bib28 article-title: Alix regulates tumor-mediated immunosuppression by controlling EGFR activity and PD-L1 presentation publication-title: Cell Rep contributor: fullname: Barber – volume: 106 start-page: 216 year: 2005 end-page: 223 ident: bib43 article-title: ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming publication-title: Blood contributor: fullname: Théry – volume: 51 start-page: 1 year: 2019 end-page: 13 ident: bib18 article-title: Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer publication-title: Exp. Mol. Med. contributor: fullname: Han – volume: 164 start-page: 1226 year: 2016 end-page: 1232 ident: bib47 article-title: Communication by extracellular vesicles: where we are and where we need to go publication-title: Cell contributor: fullname: Théry – volume: 168 start-page: 707 year: 2017 end-page: 723 ident: bib44 article-title: Primary, adaptive, and acquired resistance to cancer immunotherapy publication-title: Cell contributor: fullname: Ribas – volume: 73 start-page: 617 year: 2013 end-page: 628 ident: bib10 article-title: CD103 or LFA-1 engagement at the immune synapse between cytotoxic T cells and tumor cells promotes maturation and regulates T-cell effector functions publication-title: Cancer Res. contributor: fullname: Mami-Chouaib – volume: 10 start-page: 1078 year: 2019 ident: bib12 article-title: Cell adhesion molecules and their roles and regulation in the immune and tumor microenvironment publication-title: Front. Immunol. contributor: fullname: Fagerholm – volume: 34 start-page: 539 year: 2016 end-page: 573 ident: bib1 article-title: Coinhibitory pathways in immunotherapy for cancer publication-title: Annu. Rev. Immunol. contributor: fullname: Sharpe – volume: 9 start-page: 847 year: 2018 ident: bib2 article-title: Interferon-gamma at the crossroads of tumor immune surveillance or evasion publication-title: Front. Immunol. contributor: fullname: Oliveira – volume: 359 start-page: 1350 year: 2018 end-page: 1355 ident: bib37 article-title: Cancer immunotherapy using checkpoint blockade publication-title: Science contributor: fullname: Wolchok – volume: 4 start-page: S119 year: 2002 end-page: S125 ident: bib7 article-title: The immunological synapse publication-title: Arthritis Res contributor: fullname: Dustin – volume: 9 start-page: 676 year: 2012 end-page: 682 ident: bib41 article-title: Fiji: an open-source platform for biological-image analysis publication-title: Nat. Methods contributor: fullname: Schmid – volume: 68 start-page: 9854 year: 2008 end-page: 9864 ident: bib11 article-title: ICAM-1 has a critical role in the regulation of metastatic melanoma tumor susceptibility to CTL lysis by interfering with PI3K/AKT pathway publication-title: Cancer Res. contributor: fullname: Chouaib – volume: 30 start-page: 255 year: 2014 end-page: 289 ident: bib5 article-title: Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles publication-title: Annu. Rev. Cell Dev. Biol. contributor: fullname: Théry – volume: 8 start-page: 793 year: 2002 end-page: 800 ident: bib6 article-title: Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion publication-title: Nat. Med. contributor: fullname: Tamada – volume: 2 start-page: e23972 year: 2013 ident: bib23 article-title: Endogenous tumor-reactive CD8(+) T cells are differentiated effector cells expressing high levels of CD11a and PD-1 but are unable to control tumor growth publication-title: Oncoimmunology contributor: fullname: Dong – volume: 4 start-page: eaar2766 year: 2018 ident: bib38 article-title: Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles publication-title: Sci. Adv. contributor: fullname: Passaro – volume: 124 start-page: 133 year: 2001 end-page: 136 ident: bib45 article-title: Nonspecific B and T cell-stimulatory activity mediated by mast cells is associated with exosomes publication-title: Int. Arch. Allergy Immunol. contributor: fullname: Mécheri – volume: 306 start-page: C621 year: 2014 end-page: C633 ident: bib49 article-title: Extracellular membrane vesicles as a mechanism of cell-to-cell communication: advantages and disadvantages publication-title: Am. J. Physiol. Cell Physiol. contributor: fullname: Geraci – volume: 292 start-page: 6799 year: 2017 end-page: 6809 ident: bib22 article-title: In situ and in silico kinetic analyses of programmed cell death-1 (PD-1) receptor, programmed cell death ligands, and B7-1 protein interaction network publication-title: J. Biol. Chem. contributor: fullname: Zhu – volume: 560 start-page: 382 year: 2018 end-page: 386 ident: bib4 article-title: Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response publication-title: Nature contributor: fullname: Sun – volume: 4 start-page: 7 year: 2015 ident: bib26 article-title: Exosomes: mechanisms of uptake publication-title: J. Circ. Biomark. contributor: fullname: McCracken – volume: 26 start-page: 3745 year: 2019 end-page: 3755 ident: bib9 article-title: Exosomal PD-L1 retains immunosuppressive activity and is associated with gastric cancer prognosis publication-title: Ann. Surg. Oncol. contributor: fullname: Qu – volume: 126 start-page: 186 year: 2009 end-page: 200 ident: bib25 article-title: Dynamic expression of protective CEACAM1 on melanoma cells during specific immune attack publication-title: Immunology contributor: fullname: Schachter – volume: 367 year: 2020 ident: bib16 article-title: The biology, function, and biomedical applications of exosomes publication-title: Science contributor: fullname: LeBleu – volume: 74 start-page: 66 year: 2018 end-page: 77 ident: bib15 article-title: Biogenesis and function of ESCRT-dependent extracellular vesicles publication-title: Semin. Cell Dev. Biol. contributor: fullname: Fürthauer – volume: 6 start-page: 550 year: 2020 end-page: 558 ident: bib30 article-title: Exosomal PD-L1: roles in tumor progression and immunotherapy publication-title: Trends Cancer contributor: fullname: Yan – volume: 553 start-page: 496 year: 2018 end-page: 500 ident: bib35 article-title: Monitoring T cell-dendritic cell interactions in vivo by intercellular enzymatic labelling publication-title: Nature contributor: fullname: Victora – volume: 36 start-page: 15 year: 1995 end-page: 25 ident: bib19 article-title: Induction of ICAM-1 and HLA-DR expression by IFN-gamma in malignant melanoma cell lines publication-title: Yonsei Med. J. contributor: fullname: Kim – volume: 22 start-page: R116 year: 2012 end-page: R120 ident: bib42 article-title: The ESCRT machinery publication-title: Curr. Biol. contributor: fullname: Teis – volume: 541 start-page: 321 year: 2017 ident: 10.1016/j.devcel.2022.01.002_bib3 article-title: Elements of cancer immunity and the cancer-immune set point publication-title: Nature doi: 10.1038/nature21349 contributor: fullname: Chen – volume: 8 start-page: 793 year: 2002 ident: 10.1016/j.devcel.2022.01.002_bib6 article-title: Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion publication-title: Nat. Med. doi: 10.1038/nm730 contributor: fullname: Dong – volume: 4 start-page: 7 year: 2015 ident: 10.1016/j.devcel.2022.01.002_bib26 article-title: Exosomes: mechanisms of uptake publication-title: J. Circ. Biomark. doi: 10.5772/61186 contributor: fullname: McKelvey – volume: 164 start-page: 1226 year: 2016 ident: 10.1016/j.devcel.2022.01.002_bib47 article-title: Communication by extracellular vesicles: where we are and where we need to go publication-title: Cell doi: 10.1016/j.cell.2016.01.043 contributor: fullname: Tkach – volume: 367 year: 2020 ident: 10.1016/j.devcel.2022.01.002_bib16 article-title: The biology, function, and biomedical applications of exosomes publication-title: Science doi: 10.1126/science.aau6977 contributor: fullname: Kalluri – volume: 2 start-page: e23972 year: 2013 ident: 10.1016/j.devcel.2022.01.002_bib23 article-title: Endogenous tumor-reactive CD8(+) T cells are differentiated effector cells expressing high levels of CD11a and PD-1 but are unable to control tumor growth publication-title: Oncoimmunology doi: 10.4161/onci.23972 contributor: fullname: Liu – volume: 9 start-page: 952 year: 2018 ident: 10.1016/j.devcel.2022.01.002_bib50 article-title: LFA-1 in T cell migration and differentiation publication-title: Front. Immunol. doi: 10.3389/fimmu.2018.00952 contributor: fullname: Walling – volume: 553 start-page: 496 year: 2018 ident: 10.1016/j.devcel.2022.01.002_bib35 article-title: Monitoring T cell-dendritic cell interactions in vivo by intercellular enzymatic labelling publication-title: Nature doi: 10.1038/nature25442 contributor: fullname: Pasqual – volume: 34 start-page: 539 year: 2016 ident: 10.1016/j.devcel.2022.01.002_bib1 article-title: Coinhibitory pathways in immunotherapy for cancer publication-title: Annu. Rev. Immunol. doi: 10.1146/annurev-immunol-032414-112049 contributor: fullname: Baumeister – volume: 28 start-page: 862 year: 2018 ident: 10.1016/j.devcel.2022.01.002_bib52 article-title: Exosomal PD-L1 harbors active defense function to suppress T cell killing of breast cancer cells and promote tumor growth publication-title: Cell Res. doi: 10.1038/s41422-018-0060-4 contributor: fullname: Yang – volume: 24 start-page: 630 year: 2018 ident: 10.1016/j.devcel.2022.01.002_bib28 article-title: Alix regulates tumor-mediated immunosuppression by controlling EGFR activity and PD-L1 presentation publication-title: Cell Rep doi: 10.1016/j.celrep.2018.06.066 contributor: fullname: Monypenny – volume: 292 start-page: 6799 year: 2017 ident: 10.1016/j.devcel.2022.01.002_bib22 article-title: In situ and in silico kinetic analyses of programmed cell death-1 (PD-1) receptor, programmed cell death ligands, and B7-1 protein interaction network publication-title: J. Biol. Chem. doi: 10.1074/jbc.M116.763888 contributor: fullname: Li – volume: 397 start-page: 251 year: 2010 ident: 10.1016/j.devcel.2022.01.002_bib20 article-title: A membranous form of ICAM-1 on exosomes efficiently blocks leukocyte adhesion to activated endothelial cells publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2010.05.094 contributor: fullname: Lee – volume: 68 start-page: 9854 year: 2008 ident: 10.1016/j.devcel.2022.01.002_bib11 article-title: ICAM-1 has a critical role in the regulation of metastatic melanoma tumor susceptibility to CTL lysis by interfering with PI3K/AKT pathway publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-08-0719 contributor: fullname: Hamaï – volume: 24 start-page: 896 year: 2018 ident: 10.1016/j.devcel.2022.01.002_bib46 article-title: Clinical significance of PD-L1(+) exosomes in plasma of head and neck cancer patients publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-17-2664 contributor: fullname: Theodoraki – volume: 6 start-page: e1261243 year: 2017 ident: 10.1016/j.devcel.2022.01.002_bib31 article-title: Human tumor-derived exosomes (TEX) regulate Treg functions via cell surface signaling rather than uptake mechanisms publication-title: Oncoimmunology doi: 10.1080/2162402X.2016.1261243 contributor: fullname: Muller – volume: 9 start-page: 847 year: 2018 ident: 10.1016/j.devcel.2022.01.002_bib2 article-title: Interferon-gamma at the crossroads of tumor immune surveillance or evasion publication-title: Front. Immunol. doi: 10.3389/fimmu.2018.00847 contributor: fullname: Castro – volume: 177 start-page: 414 year: 2019 ident: 10.1016/j.devcel.2022.01.002_bib36 article-title: Suppression of Exosomal PD-L1 induces systemic anti-tumor immunity and memory publication-title: Cell doi: 10.1016/j.cell.2019.02.016 contributor: fullname: Poggio – volume: 26 start-page: 3745 year: 2019 ident: 10.1016/j.devcel.2022.01.002_bib9 article-title: Exosomal PD-L1 retains immunosuppressive activity and is associated with gastric cancer prognosis publication-title: Ann. Surg. Oncol. doi: 10.1245/s10434-019-07431-7 contributor: fullname: Fan – volume: 73 start-page: 617 year: 2013 ident: 10.1016/j.devcel.2022.01.002_bib10 article-title: CD103 or LFA-1 engagement at the immune synapse between cytotoxic T cells and tumor cells promotes maturation and regulates T-cell effector functions publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-12-2569 contributor: fullname: Franciszkiewicz – volume: 8 start-page: 1069 year: 2018 ident: 10.1016/j.devcel.2022.01.002_bib51 article-title: Fundamental mechanisms of immune checkpoint blockade therapy publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-18-0367 contributor: fullname: Wei – volume: 51 start-page: 1 year: 2019 ident: 10.1016/j.devcel.2022.01.002_bib18 article-title: Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer publication-title: Exp. Mol. Med. contributor: fullname: Kim – volume: 124 start-page: 133 year: 2001 ident: 10.1016/j.devcel.2022.01.002_bib45 article-title: Nonspecific B and T cell-stimulatory activity mediated by mast cells is associated with exosomes publication-title: Int. Arch. Allergy Immunol. doi: 10.1159/000053691 contributor: fullname: Skokos – volume: 24 start-page: 351 year: 1997 ident: 10.1016/j.devcel.2022.01.002_bib32 article-title: In vitro comparison between mouse B16 and human melanoma cell lines of the expression of ICAM-1 induced by cytokines and/or hyperthermia publication-title: J. Dermatol. doi: 10.1111/j.1346-8138.1997.tb02805.x contributor: fullname: Nakayama – volume: 11 start-page: 783 year: 2014 ident: 10.1016/j.devcel.2022.01.002_bib40 article-title: Improved vectors and genome-wide libraries for CRISPR screening publication-title: Nat. Methods doi: 10.1038/nmeth.3047 contributor: fullname: Sanjana – volume: 113 start-page: 1977 year: 2009 ident: 10.1016/j.devcel.2022.01.002_bib33 article-title: Activated T cells recruit exosomes secreted by dendritic cells via LFA-1 publication-title: Blood doi: 10.1182/blood-2008-08-174094 contributor: fullname: Nolte-'t Hoen – volume: 10 start-page: 1078 year: 2019 ident: 10.1016/j.devcel.2022.01.002_bib12 article-title: Cell adhesion molecules and their roles and regulation in the immune and tumor microenvironment publication-title: Front. Immunol. doi: 10.3389/fimmu.2019.01078 contributor: fullname: Harjunpää – volume: 6 start-page: 18 year: 2018 ident: 10.1016/j.devcel.2022.01.002_bib24 article-title: Exosome-based cell-cell communication in the tumor microenvironment publication-title: Front. Cell Dev. Biol. doi: 10.3389/fcell.2018.00018 contributor: fullname: Maia – volume: 168 start-page: 707 year: 2017 ident: 10.1016/j.devcel.2022.01.002_bib44 article-title: Primary, adaptive, and acquired resistance to cancer immunotherapy publication-title: Cell doi: 10.1016/j.cell.2017.01.017 contributor: fullname: Sharma – volume: 22 start-page: R116 year: 2012 ident: 10.1016/j.devcel.2022.01.002_bib42 article-title: The ESCRT machinery publication-title: Curr. Biol. doi: 10.1016/j.cub.2012.01.028 contributor: fullname: Schmidt – volume: 4 start-page: eaar2766 year: 2018 ident: 10.1016/j.devcel.2022.01.002_bib38 article-title: Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles publication-title: Sci. Adv. doi: 10.1126/sciadv.aar2766 contributor: fullname: Ricklefs – volume: 527 start-page: 329 year: 2015 ident: 10.1016/j.devcel.2022.01.002_bib14 article-title: Tumour exosome integrins determine organotropic metastasis publication-title: Nature doi: 10.1038/nature15756 contributor: fullname: Hoshino – volume: 4 start-page: S119 issue: suppl 3 year: 2002 ident: 10.1016/j.devcel.2022.01.002_bib7 article-title: The immunological synapse publication-title: Arthritis Res doi: 10.1186/ar559 contributor: fullname: Dustin – volume: 104 start-page: 3257 year: 2004 ident: 10.1016/j.devcel.2022.01.002_bib29 article-title: Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells publication-title: Blood doi: 10.1182/blood-2004-03-0824 contributor: fullname: Morelli – volume: 30 start-page: 255 year: 2014 ident: 10.1016/j.devcel.2022.01.002_bib5 article-title: Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles publication-title: Annu. Rev. Cell Dev. Biol. doi: 10.1146/annurev-cellbio-101512-122326 contributor: fullname: Colombo – volume: 103 start-page: 229 year: 2019 ident: 10.1016/j.devcel.2022.01.002_bib8 article-title: Prospective immunophenotyping of CD8(+) T cells and associated clinical outcomes of patients with oligometastatic prostate cancer treated with metastasis-directed SBRT publication-title: Int. J. Radiat. Oncol. Biol. Phys. doi: 10.1016/j.ijrobp.2018.09.001 contributor: fullname: Evans – volume: 560 start-page: 382 year: 2018 ident: 10.1016/j.devcel.2022.01.002_bib4 article-title: Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response publication-title: Nature doi: 10.1038/s41586-018-0392-8 contributor: fullname: Chen – volume: 74 start-page: 66 year: 2018 ident: 10.1016/j.devcel.2022.01.002_bib15 article-title: Biogenesis and function of ESCRT-dependent extracellular vesicles publication-title: Semin. Cell Dev. Biol. doi: 10.1016/j.semcdb.2017.08.022 contributor: fullname: Juan – volume: 359 start-page: 1350 year: 2018 ident: 10.1016/j.devcel.2022.01.002_bib37 article-title: Cancer immunotherapy using checkpoint blockade publication-title: Science doi: 10.1126/science.aar4060 contributor: fullname: Ribas – volume: 130 start-page: 1784 year: 1983 ident: 10.1016/j.devcel.2022.01.002_bib17 article-title: Interleukin 2-mediated immune interferon (IFN-gamma) production by human T cells and T cell subsets publication-title: J. Immunol. doi: 10.4049/jimmunol.130.4.1784 contributor: fullname: Kasahara – volume: 161 start-page: 4016 year: 1998 ident: 10.1016/j.devcel.2022.01.002_bib48 article-title: Affinity and kinetic analysis of the molecular interaction of ICAM-1 and leukocyte function-associated antigen-1 publication-title: J. Immunol. doi: 10.4049/jimmunol.161.8.4016 contributor: fullname: Tominaga – volume: 9 start-page: 676 year: 2012 ident: 10.1016/j.devcel.2022.01.002_bib41 article-title: Fiji: an open-source platform for biological-image analysis publication-title: Nat. Methods doi: 10.1038/nmeth.2019 contributor: fullname: Schindelin – volume: 29 start-page: 590 year: 2016 ident: 10.1016/j.devcel.2022.01.002_bib27 article-title: The YUMM lines: a series of congenic mouse melanoma cell lines with defined genetic alterations publication-title: Pigment Cell Melanoma Res doi: 10.1111/pcmr.12498 contributor: fullname: Meeth – volume: 41 start-page: D1040 year: 2013 ident: 10.1016/j.devcel.2022.01.002_bib39 article-title: Interferome v2.0: an updated database of annotated interferon-regulated genes publication-title: Nucleic Acids Res. doi: 10.1093/nar/gks1215 contributor: fullname: Rusinova – volume: 36 start-page: 15 year: 1995 ident: 10.1016/j.devcel.2022.01.002_bib19 article-title: Induction of ICAM-1 and HLA-DR expression by IFN-gamma in malignant melanoma cell lines publication-title: Yonsei Med. J. doi: 10.3349/ymj.1995.36.1.15 contributor: fullname: Kim – volume: 126 start-page: 186 year: 2009 ident: 10.1016/j.devcel.2022.01.002_bib25 article-title: Dynamic expression of protective CEACAM1 on melanoma cells during specific immune attack publication-title: Immunology doi: 10.1111/j.1365-2567.2008.02888.x contributor: fullname: Markel – volume: 52 start-page: 17 year: 2020 ident: 10.1016/j.devcel.2022.01.002_bib13 article-title: Top 10 challenges in cancer immunotherapy publication-title: Immunity doi: 10.1016/j.immuni.2019.12.011 contributor: fullname: Hegde – volume: 6 start-page: 550 year: 2020 ident: 10.1016/j.devcel.2022.01.002_bib30 article-title: Exosomal PD-L1: roles in tumor progression and immunotherapy publication-title: Trends Cancer doi: 10.1016/j.trecan.2020.03.002 contributor: fullname: Morrissey – volume: 106 start-page: 216 year: 2005 ident: 10.1016/j.devcel.2022.01.002_bib43 article-title: ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming publication-title: Blood doi: 10.1182/blood-2005-01-0220 contributor: fullname: Segura – volume: 17 start-page: 355 year: 2019 ident: 10.1016/j.devcel.2022.01.002_bib21 article-title: Clinical significance of PD-L1 expression in serum-derived exosomes in NSCLC patients publication-title: J. Transl. Med. doi: 10.1186/s12967-019-2101-2 contributor: fullname: Li – volume: 306 start-page: C621 year: 2014 ident: 10.1016/j.devcel.2022.01.002_bib49 article-title: Extracellular membrane vesicles as a mechanism of cell-to-cell communication: advantages and disadvantages publication-title: Am. J. Physiol. Cell Physiol. doi: 10.1152/ajpcell.00228.2013 contributor: fullname: Turturici – volume: 12 start-page: 19 year: 2010 ident: 10.1016/j.devcel.2022.01.002_bib34 article-title: Rab27a and Rab27b control different steps of the exosome secretion pathway publication-title: Nat. Cell Biol. doi: 10.1038/ncb2000 contributor: fullname: Ostrowski |
SSID | ssj0016180 |
Score | 2.6273406 |
Snippet | Tumor-derived extracellular vesicles (TEVs) suppress the proliferation and cytotoxicity of CD8+ T cells, thereby contributing to tumor immune evasion. Here, we... Tumor-derived extracellular vesicles (TEVs) suppress the proliferation and cytotoxicity of CD8 T cells, thereby contributing to tumor immune evasion. Here, we... Tumor-derived extracellular vesicles (TEVs) suppress the proliferation and cytotoxicity of CD8+ T cells, thereby contributing to tumor immune evasion. Here, we... Tumor-derived extracellular vesicles (TEVs) suppress the proliferation and cytotoxicity of CD8 + T cells, thereby contributing to tumor immune evasion. Here we... |
SourceID | pubmedcentral proquest crossref pubmed elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 329 |
SubjectTerms | Animals B7-H1 Antigen - metabolism CD8+ T cells CD8-Positive T-Lymphocytes - drug effects CD8-Positive T-Lymphocytes - immunology Cell Adhesion - drug effects Cell Communication - drug effects Cell Line, Tumor Disease Models, Animal exosome Exosomes - drug effects Exosomes - metabolism Exosomes - ultrastructure extracellular vesicles ICAM-1 immune suppression Immunosuppression Therapy Intercellular Adhesion Molecule-1 - metabolism Interferon-gamma - pharmacology Melanoma - pathology Mice Mice, Inbred C57BL Neoplasm Proteins - metabolism PD-L1 Protein Binding - drug effects T-Lymphocytes - cytology T-Lymphocytes - immunology Up-Regulation - drug effects |
Title | ICAM-1-mediated adhesion is a prerequisite for exosome-induced T cell suppression |
URI | https://dx.doi.org/10.1016/j.devcel.2022.01.002 https://www.ncbi.nlm.nih.gov/pubmed/35085484 https://www.proquest.com/docview/2623883018 https://pubmed.ncbi.nlm.nih.gov/PMC8881799 |
Volume | 57 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ZSwMxEA4eCL6It_UoEXwN3TOJj1os1aovVulb2HSndAW3tYfov_G3-Muc2aNYFQRfFnY32Q0zyeSbzMXYCQVDuqAcgbs1iEB5VA3QkwLsqY59oIxxdKB_cyub98FVJ-wssHoZC0NulYXsz2V6Jq2LJ7WCmrVhktTucK0GoXaUR9EmuE0usmUP0S9O9uWz84fW9cyYIN2sgBq1F9ShjKDL3LxieOkC2SA8L8vfWZyv_LJD_USg3x0pv-xMjXW2VkBKfpaPeoMtQLrJVvIik29bjIo63qAKl8WIIL7kUdwHOiPjyZhHfDiCETxPE7Iic0SwHF4H48ETCFTWke0xb3-80-k-H0-HhdNsus3ajYt2vSmKSgqiG0h_IoJTq8IoVqgNWVywKoq9SDqBCmVX90BaF6SWEWlfPiqMtictKq4QxtK1PrjK32FL6SCFPcZ7lM6UTJm40gOASNOXusq30kpwem6FiZJ4ZpjnyzClI9mjyYltiNjGcQ0Su8JUSWEzx3eDIv2PnsclQwwuCaJElMJgOjYeQjqtUXLpCtvNGTQbi4-AFJW0AP87x7pZA0q3Pf8mTfpZ2m2tNaXP2__3iA_YKt1lPt_qkC1NRlM4QkgzsdViylYR1F-28HrZOf8E32j2gw |
link.rule.ids | 230,315,783,787,888,3515,27583,27938,27939,45677,45888 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR3ZTuMwcMQhBC8I2Kssh5F4tZrTNo8sWlSg5YWCeLPiZiqCtGm3B4K_4Vv4sp3JUVEWCYnX2E6smcx9ARxyMaSP2pMkrVFGOuBpgIGS6I5MGiJ3jGOHfudSta6j89v4dgFO6loYTquseH_J0wtuXT1pVtBsDrOseUW0GsXG0wFXm5CYXIRl0gY0WWDLx79uLtqzYILyiwFqvF_ygbqCrkjzSvGhhxyDCIKif2flX3lHQv2vgb5NpHwlmU43YL1SKcVxeetNWMB8C1bKIZNPX4CHOnbIhCtqREi_FEl6h-wjE9lYJGI4whH-nWYcRRakwQp8HIwHf1CSsU5oT0X35Zm9-2I8HVZJs_lX6J7-7p60ZDVJQfYiFU5kdOR0nKSarCFHBKuTNEiUF-lY9UwflfNRGZWw9RWSwej6ypHhinGqfBeir8NvsJQPcvwBos_tTDmUSZQeISaG39TToVNOodf3GyBr4Nlh2S_D1olk97YEtmVgW8-3BOwG6BrCdg7vllj6BycPaoRYIgmGRJLjYDq2Aal0xhDnMg34XiJodpeQFFIy0iL67hzqZhu43fb8Sp7dFW23jTHcPm_70zfeh9VWt9O27bPLi5-wxitF_rfegaXJaIq7pN5M3F71-_4D_2n3dA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=ICAM-1-mediated+adhesion+is+a+prerequisite+for+exosome-induced+T%C2%A0cell+suppression&rft.jtitle=Developmental+cell&rft.au=Zhang%2C+Wei&rft.au=Zhong%2C+Wenqun&rft.au=Wang%2C+Beike&rft.au=Yang%2C+Jiegang&rft.date=2022-02-07&rft.issn=1534-5807&rft.volume=57&rft.issue=3&rft.spage=329&rft.epage=343.e7&rft_id=info:doi/10.1016%2Fj.devcel.2022.01.002&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_devcel_2022_01_002 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1534-5807&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1534-5807&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1534-5807&client=summon |